Anin vivorole for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate-Reference-Cited by-同舟云学术

Anin vivorole for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate

Published:2014-10-24 Issue:21 Volume:171 Page:4902-4913
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Williams L J¹,Mukherjee D¹,Fisher M¹,Reyes-Aldasoro C C¹,Akerman S¹,Kanthou C¹,Tozer G M¹

Affiliation:

1. Tumour Microcirculation Group, Sheffield Cancer Research Centre, Department of Oncology, School of Medicine; The University of Sheffield; Sheffield UK

Funder

Cancer Research UK

Yorkshire Cancer Research

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12817/fullpdf

Reference58 articles.

1. Activation of RhoA and ROCK are essential for detachment of migrating leukocytes;Alblas;Mol Biol Cell,2001

2. The Concise Guide to PHARMACOLOGY 2013/14: Enzymes;Alexander;British Journal of Pharmacology,2013

3. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury;Bao;Cardiovasc Res,2004

4. Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632;Beuge;Pharmaceut Res,2011

5. Combretastatin A-4 prodrug inhibits growth of human non-small cell lung cancer in a murine xenotransplant model;Boehle;Ann Thorac Surg,2001

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vascular Shutdown by Photodynamic Therapy Using Talaporfin Sodium;Cancers;2020-08-21

2. The influence of hypoxia and energy depletion on the response of endothelial cells to the vascular disrupting agent combretastatin A-4-phosphate;Scientific Reports;2020-06-18

3. Vascular disrupting effect of combretastatin A-4 phosphate with inhibition of vascular endothelial cadherin in canine osteosarcoma-xenografted mice;Research in Veterinary Science;2019-02

4. Evaluation of Sydnone-Based Analogues of Combretastatin A-4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy;ChemMedChem;2018-11-08

5. Antitubulin sulfonamides: The successful combination of an established drug class and a multifaceted target;Medicinal Research Reviews;2018-10-25